Topiramate (lithium) - HY-B0122A
Catalog #
HY-B0122A
Topiramate (McN 4853) lithium is a broad-spectrum antiepileptic agent. Topiramate lithium is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase[1][2][3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B0122A/Topiramate-lithium-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | Get quote |
| Shipping | Room temperature |
| Application | Neuroscience-Neuromodulation |
| Alternative Names | McN 4853 (lithium); RWJ 17021 (lithium) |
| CAS | 488127-53-3 |
| MWT | 346.30 |
| Solubility | 10 mM in DMSO |
| Clinical Information | Launched |
| Target | Calcium Channel;Carbonic Anhydrase;GABA Receptor;iGluR;Potassium Channel;Sodium Channel |
| Application: | Neuroscience-Neuromodulation |
|---|